# Katherine A. Hoadley

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/katherine-a-hoadley/

## Facts

| Field | Value |
| --- | --- |
| Citations | 160,387 |
| Field | Cancer Genomics and Diagnostics |
| h-index | 136 |
| i10-index | 247 |
| Last Known Institution | University of North Carolina at Chapel Hill |
| OpenAlex ID | https://openalex.org/A5002773659 |
| ORCID iD | https://orcid.org/0000-0002-1216-477X |
| Works | 810 |

## Researcher papers

Showing 12 of 14.

- [An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics](https://scholariq.org/papers/an-integrated-tcga-pan-cancer-clinical-data-resource-to-drive-high-quality/)
- [Integrated Genomic Characterization of Papillary Thyroid Carcinoma](https://scholariq.org/papers/integrated-genomic-characterization-of-papillary-thyroid-carcinoma/)
- [Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer](https://scholariq.org/papers/cell-of-origin-patterns-dominate-the-molecular-classification-of-10-000-tumors/)
- [Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma](https://scholariq.org/papers/identification-of-a-cpg-island-methylator-phenotype-that-defines-a-distinct/)
- [Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma](https://scholariq.org/papers/molecular-profiling-reveals-biologically-discrete-subsets-and-pathways-of/)
- [Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma](https://scholariq.org/papers/integrated-genomic-characterization-of-pancreatic-ductal-adenocarcinoma/)
- [Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial](https://scholariq.org/papers/carboplatin-in-brca1-2-mutated-and-triple-negative-breast-cancer-brcaness/)
- [Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer](https://scholariq.org/papers/dynamic-reprogramming-of-the-kinome-in-response-to-targeted-mek-inhibition-in/)
- [Integrative Molecular Characterization of Malignant Pleural Mesothelioma](https://scholariq.org/papers/integrative-molecular-characterization-of-malignant-pleural-mesothelioma/)
- [Integrated Molecular Characterization of Testicular Germ Cell Tumors](https://scholariq.org/papers/integrated-molecular-characterization-of-testicular-germ-cell-tumors/)
- [Integrated Molecular Characterization of Uterine Carcinosarcoma](https://scholariq.org/papers/integrated-molecular-characterization-of-uterine-carcinosarcoma/)
- [Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib](https://scholariq.org/papers/molecular-heterogeneity-and-response-to-neoadjuvant-human-epidermal-growth/)

## Researcher topics

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)

## Researcher university

- [University of North Carolina at Chapel Hill](https://scholariq.org/institutions/university-of-north-carolina-at-chapel-hill/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.